Professional Documents
Culture Documents
(Download PDF) Cardioskeletal Myopathies in Children and Young Adults 1St Edition John Lynn Jefferies Online Ebook All Chapter PDF
(Download PDF) Cardioskeletal Myopathies in Children and Young Adults 1St Edition John Lynn Jefferies Online Ebook All Chapter PDF
https://textbookfull.com/product/cancer-in-adolescents-and-young-
adults-2nd-edition-archie-bleyer/
https://textbookfull.com/product/working-with-violence-and-
confrontation-using-solution-focused-approaches-creative-
practice-with-children-young-people-and-adults-judith-milner/
https://textbookfull.com/product/management-of-adrenal-masses-in-
children-and-adults-1st-edition-electron-kebebew-eds/
https://textbookfull.com/product/family-in-children-s-and-young-
adult-literature-1st-edition-eleanor-spencer/
Transgender Children and Young People 1st Edition
Heather Brunskell-Evans
https://textbookfull.com/product/transgender-children-and-young-
people-1st-edition-heather-brunskell-evans/
https://textbookfull.com/product/popular-culture-voice-and-
linguistic-diversity-young-adults-on-and-offline-1st-edition-
sender-dovchin/
https://textbookfull.com/product/skills-in-counselling-and-
psychotherapy-with-children-and-young-people-lorraine-sherman/
https://textbookfull.com/product/living-and-working-in-poverty-
in-latin-america-trajectories-of-children-youth-and-adults-maria-
eugenia-rausky/
https://textbookfull.com/product/children-young-people-and-the-
press-in-a-transitioning-society-faith-gordon/
Cardioskeletal Myopathies
in Children and Young Adults
Edited by
John Lynn Jefferies
Burns C. Blaxall
Jeffrey Robbins
Jeffrey A. Towbin
No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including
photocopying, recording, or any information storage and retrieval system, without permission in writing from the publisher. Details on
how to seek permission, further information about the Publisher’s permissions policies and our arrangements with organizations such
as the Copyright Clearance Center and the Copyright Licensing Agency, can be found at our website: www.elsevier.com/permissions.
This book and the individual contributions contained in it are protected under copyright by the Publisher (other than as
may be noted herein).
Notices
Knowledge and best practice in this field are constantly changing. As new research and experience broaden our understanding, changes
in research methods, professional practices, or medical treatment may become necessary.
Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information,
methods, compounds, or experiments described herein. In using such information or methods they should be mindful of their own
safety and the safety of others, including parties for whom they have a professional responsibility.
To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors, assume any liability for any injury and/or
damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods,
products, instructions, or ideas contained in the material herein.
ISBN: 978-0-12-800040-3
D.J. Abrams Harvard Medical School, Boston, MA, S.R. Lalani Baylor College of Medicine, Houston, TX,
United States United States
A. Axelsson University of Copenhagen, Copenhagen, B.J. Landis Indiana University School of Medicine,
Denmark Indianapolis, IN, United States
B.C. Blaxall Cincinnati Children’s Hospital Medical D.L. Mann Washington University School of Medicine,
Center, Cincinnati, OH, United States St Louis, MO, United States
S. Bogdanovich The University of Chicago, Chicago, IL, J. Mathew Royal Children’s Hospital, Melbourne, VIC,
United States; Northwestern University Feinberg School Australia
of Medicine, Chicago, IL, United States E.M. McNally The University of Chicago, Chicago, IL,
S.C. Brown University of London, London, United United States; Northwestern University Feinberg School
Kingdom of Medicine, Chicago, IL, United States
M. Byku Washington University School of Medicine, L. Mestroni University of Colorado, Aurora, CO, United
St Louis, MO, United States States
S. Chanprasert Baylor College of Medicine, Houston, S.D. Miyamoto University of Colorado School of
TX, United States Medicine, Aurora, CO, United States
S.D. Colan Harvard Medical School, Boston, MA, United R.A. Moore Cincinnati Children’s Hospital Medical
States Center, Cincinnati, OH, United States
W.J. Craigen Baylor College of Medicine, Houston, TX, A. Redington Cincinnati Children’s Hospital Medical
United States; Texas Children’s Hospital, Houston, TX, Center, Cincinnati, OH, United States
United States J. Robbins Children’s Hospital Research Foundation,
H.C. DeSena Cincinnati Children’s Hospital Medical Cincinnati, OH, United States
Center, Cincinnati, OH, United States T.D. Ryan Cincinnati Children’s Hospital Medical Center,
A. El-Gharbawy University of Pittsburgh School of The University of Cincinnati College of Medicine,
Medicine, Pittsburgh, PA, United States; Children’s Cincinnati, OH, United States
Hospital of Pittsburgh, Pittsburgh, PA, United States J.E. Saffitz Harvard Medical School, Boston, MA, United
B.B. Gardner The University of Chicago, Chicago, IL, States
United States; Northwestern University Feinberg School C.A. Sewry UCL Institute of Child Health, London, United
of Medicine, Chicago, IL, United States Kingdom
C.Y. Ho Brigham and Women’s Hospital, Boston, MA,
R.J. Solaro University of Illinois at Chicago, Chicago, IL,
United States
United States
J.L. Jefferies Cincinnati Children’s Hospital Medical
D.S. Spar Cincinnati Children’s Hospital Medical Center,
Center, The University of Cincinnati College of
Cincinnati, OH, United States
Medicine, Cincinnati, OH, United States
B.L. Stauffer University of Colorado School of Medicine,
D.A. Kass Johns Hopkins University School of Medicine,
Aurora, CO, United States
Baltimore, MD, United States
C.C. Sucharov University of Colorado School of
Z. Khuchua Cincinnati Children’s Hospital Medical
Medicine, Aurora, CO, United States
Center, Cincinnati, OH, United States
xiii
xiv List of Contributors
M.E. Sweet University of Colorado, Aurora, CO, United W. Whiteside Cincinnati Children’s Hospital Medical
States Center, Cincinnati, OH, United States
M.R.G. Taylor University of Colorado, Aurora, CO, I. Wilmot Cincinnati Children’s Hospital Medical Center,
United States The University of Cincinnati College of Medicine,
J.A. Towbin Le Bonheur Children’s Hospital and University Cincinnati, OH, United States
of Tennessee Health Science Center, Memphis, TN,
United States
J. Vockley University of Pittsburgh School of Medicine,
Pittsburgh, PA, United States; Children’s Hospital of
Pittsburgh, Pittsburgh, PA, United States
Cardioskeletal Myopathies: Foreword
The development of low-cost, high-throughput gene sequencing technologies capable of interrogating the entire human
genome has led to a dramatic acceleration in the pace of scientific discovery and the development of novel therapies that
have the potential to modify and even cure genetic disease. For general physicians, this emerging complexity might seem
a little overwhelming and perhaps of limited relevance to everyday clinical practice, but it is already clear that while many
genetic disorders are rare, they can masquerade as more common diseases and as a consequence are often misdiagnosed or
overlooked, sometimes with devastating consequences for individual patients and their families.
Genetic diseases of the heart and blood vessels were among the first conditions for which the genetic basis was char-
acterized. This book is dedicated to one subgroup of heritable disorders—the cardioskeletal myopathies—that can present
throughout life with a predominant skeletal myopathy or primarily with heart failure, arrhythmia, and sudden death. The
latter scenario is particularly common in disorders such as laminopathies, dystrophinopathies, and desminopathies, which
can present for the first time with heart block, tachyarrhythmia, and ventricular failure. However, even in disorders that
present with neuromuscular manifestations, cardiac complications are common and as neuromuscular care improves are
becoming the major prognostic variable.
In this textbook, some of the world’s greatest authorities on cardiac and skeletal muscle have come together to pro-
duce an A to Z of striated muscle disorders, beginning with the molecular biology and physiology of normal muscle and
then moving through the mechanisms and consequences of genetic defects to the scenarios that specialists and generalists
encounter in their clinical practice, whatever their subspecialty interest. Finally, these different strands are brought together
in a review of the therapeutic implications of a specific molecular diagnosis.
The importance of a personalized approach to medicine is increasingly emphasized in public health policy and in the
training of new medical practitioners. This textbook is a significant contribution to the collective effort to improve under-
standing of the pathophysiology of cardioskeletal myopathies and will help physicians adapt and evolve their skills for the
new era of molecular medicine.
P. Elliott
University College London & St. Bartholomew’s Hospital,
London, United Kingdom
xv
Chapter 1
INTRODUCTION
Ventricular systolic dysfunction is a hallmark of many patients with congenital heart disease. Given its complex genetic
roots and anatomical consequences, dysfunction can manifest as depressed or supra-normal contractile performance
with dilative or hypertrophic remodeling, fibrosis with restrictive physiology, and/or marked changes in pressure/volume
loads. Over the past 15 years, accurate and specific methods to assess myocyte and chamber function combined with
powerful genetic tools to dissect causes have yielded major new insights into how systolic function is regulated and
altered by disease. Most of these data stem from analyses in animal models or adult human explanted hearts, whereas
results from pediatric congenital heart disease subjects remain scant due to ethical considerations. Nevertheless, the
research has yielded new insights and methodologies undoubtedly relevant to childhood disease. In this chapter, I review
the mechanisms underlying systolic chamber function and its acute regulation, how it is assessed—focusing on in vivo
characterization by pressure-volume relationships, its interaction with vascular and pericardial loading, and the influ-
ence of disease and therapies.
(A) (B)
CONTROL FHC
MyBPC-/-
1 Myocarditis
Normalized
MKK3/p38 oe
Elastance
100 100 TnI t/t (DCM)
Desmin -/-
PRESSURE (mmHg)
0
0 20 40 60 80 100 120
0
Time (ms)
0
0 50 100 150 0 50 100 150 (C)
VOLUME (mL) VOLUME (mL) 12
%∆ in Pressure-Volume Area
WT R403Q 10
120 120 8
(mmHg*µ L)
80 80 6
4
40 40
2 * *
0 0 0
20 30 40 50 60 20 30 40 50 60
VOLUME µ L VOLUME µL
/-
IP -/-
T -/-
-
T
PC
AI PC
W PC
W
-
yB
yB
yB
M
M
M
+
+
FIGURE 1.1 (A) Examples of ventricular function depicted as pressure-volume relations from a normal human subject (control), a patient with familial
hypertrophic cardiomyopathy (FHC), and corresponding control and mouse mutant models (R403Q) of a similar hypertrophic disease. In both human and
mouse model, there is a rise in systolic stiffening—indicated by the slope (end-systolic elastance) of the line connecting the upper left corners of these
relationships—known as the end-systolic PV relation. This was the first example reported where a mouse model of human genetic disease was shown to
recapitulate in vivo cardiac behavior in patients. (B) Deletion of myosin-binding protein C (MyBP-C) markedly abbreviates the time course of systole—
shown here by normalized elastance activation curves. This early onset relaxation is compared with mouse models where the heart is dysfunctional due to
inflammatory (autoimmune myocarditis), signaling (over expression (oe) of MKK3/p38 MAP kinase), protein cleavage (trunctation mutation of troponin I),
or gene deletion (desmin knockout). (C) MyBP-C phosphorylation plays a key role in beta-adrenergic stimulation. Data show percent improvement in
systolic function based on pressure-volume area index from isoproterenol infusion. MyBP-C−/− mice with wild-type (WT) cardiomyocyte reexpressed
showed full rescue of the adrenergic reserve phenotype, whereas those with a form of MyBP-C that could not be PKA phosphorylated (AllP-) appear
similar to mice without the protein at all.
Once generated, sarcomere derived force is transduced to the plasma membrane to shorten the cell against its load.
This involves structural complexes including the actin-anchoring Z-disk at the terminal ends of the sarcomere [20] and
myosin-anchoring M-band region in its center [21]. The Z-disk is linked to intermediate filaments that transduce force to
membrane shortening and external load imposed by the interstitium. The latter includes the dystro-sarcoglycan complex
and integrin-focal adhesion complexes [22,23]. Gene deletion of these critical transduction proteins such as dystrophin,
laminin, sarcoglycan, muscle lim proteins, obscurin, and others, generally results in depressed dilated heart disease, reca-
pitulating changes observed in humans [9].
Systolic function is also determined by calcium homeostasis [24–27]. Excitation-contraction coupling is a cyclical process,
with each heartbeat initiated by the voltage-gated calcium channel opening that is followed by a release of Ca2+ from the
internal sarcoplasmic reticular (SR) pool. The latter is regulated by a Ca2+ uptake process involving the SR calcium ATPase
and multiple regulating proteins, including phospholamban, calsequestrin, hematopoietic lineage substrate-1-associated pro-
tein X-1 (HAX-1), sarcolipin, and phosphatase inhibitor I1 [28–31]. SR Ca2+ release is controlled by the ryanodine-sensitive
calcium release channel RyR2 [32]. These proteins are often altered in heart disease at the transcriptional, translational, and/
or posttranslational levels. For example, phosphorylation by calcium-calmodulin–dependent kinase IIδ and PKA, increase SR
calcium release by modifying the ryanodine receptor [32–35], whereas SUMOylation of the SERCA2a is thought to enhance
its uptake capacity [36].
Systolic function is also influenced by coupling of the cell to its interstitial environment and vascular supply. Changes
in apparent force (or pressure) generation can reflect both myofilament contractile capacity and material stiffness of the
interstitium. The latter can be altered by scar as occurs with myocardial infarction, diffuse fibrosis, edema, and inflamma-
tion. Myocyte responses to increased work-load trigger a signaling cascade that engages myocytes/cytokines impacting
fibrosis, angiogenesis, and interstitial remodeling, and myocytes appear quite central in coordinating this signaling [37,38].
For example, selective gene suppression of cardiomyocyte transforming growth factor beta receptors not only markedly
enhances the cardiac functional response to sustained pressure-overload, but does so while blocking interstitial fibrosis and
Ventricular Systolic Function Chapter | 1 5
promoting angiogenesis [39]. Myocyte signaling also potently regulates inflammation in the peri-infarct zone, controlling
neutrophil accumulation and activation of matrix metalloproteinases. Myocyte derived secretion of various factors, includ-
ing the antiinflammatory GDF-15 [40] and ER-stress protective thrombospondin-4 [41] play a role in cytoprotection in the
stressed heart. Recent studies using stem cells have revealed secretion of nanoparticle exosomes as a stress-communication
system [42–44]. These vesicles contain microRNAs (miRNAs) that likely transmit key information regarding muscle func-
tion and stress to other cells and organs. Secreted miRNAs have been detected in the blood of patients with dilated heart
disease, and may also signal cardiac regional disturbances such as those produced by dyssynchronous contraction from a
conduction delay.
Ventricular systolic dysfunction is frequently associated with profound changes in chamber geometry, either dilation or
small cavities with excessive wall thickness. Indeed our most common metric for systolic dysfunction, ejection fraction,
largely parameterizes the extent of chamber dilation rather than contractility. This is because the numerator (stroke volume)
is less altered until heart disease becomes very advanced, whereas the denominator (end-diastolic volume) can change
substantially with chronic remodeling. Morphological restructuring of the heart involves breakdown and resynthesis of the
interstitium, a process involving metalloproteinases and their inhibitors and matrix signaling and coordination proteins. This
dynamic change itself contributes to systolic dysfunction [45–47]. Myocyte geometry is also transformed (longer-thinner
in dilated chambers) and this too plays a role in disease [48]. A general assumption has been that enlarged (hypertrophied)
myocytes synthesize more myofilaments to enable greater force development to counter wall stress. However, studies
have found maximal force generating capacity to be little changed despite larger cells that may relate to heterogeneity of
myofilament structure and function [49–51]. This questions the “adaptive” nature of myocardial hypertrophy, since this
concept depends on the functionality of myofibrils added into the enlarged cells.
FIGURE 1.2 (A) Schematic showing impact of increased loading on myocyte contraction. With an acute rise in sarcomere stretch of a cell that can
contract against an auxotonic load, there is an immediate increase in developed force, referred to as the Frank-Starling mechanism. This is calcium inde-
pendent, and followed by a more gradual further increase in developed force coupled with a calcium increase—or Anrep effect. (B) The Anrep effect, or
stress-stimulated contractility increase is markedly curtained by activation of protein kinase G by exposure to cyclic GMP (cGMP). Both the calcium and
force rise after the initial FS effect are suppressed. (C) Gene deletion of TRPC6 also blunts the Anrep response in isolated myocytes. Here the percent
force rise following the initial Frank-Starling effect (e.g., ΔF1 to ΔF2, in Fig. 1.2A) is shown. The ∼25% normal rise is reduced by about a third in cells
lacking TRPC6, and reduced by nearly 80% by cGMP exposure. The latter does not occur at all however, if TRPC6 is missing, thus PKG targets TRPC6
to effect the Anrep mechanism. (D) In a mouse model of Duchenne muscular dystrophy, the Anrep effect is more than doubled over control (dashed line),
but can be normalized by selective blockade of TRPC6. Data modified from Seo K, Rainer PP, Lee DI, Hao S, Bedja D, Birnbaumer L, et al. Hyperactive
adverse mechanical stress responses in dystrophic heart are coupled to transient receptor potential canonical 6 and blocked by cGMP-protein kinase G
modulation. Circ Res 2014;114:823–32.
its cardiac output despite increases in afterload pressure, a behavior coined “homeometric autoregulation” [68]. Several
theories have been forwarded to explain this behavior. One involves Ca2+ entry from reverse mode Na+-Ca2+ exchange that
is triggered by a rise in intracellular sodium [69]. In this scheme, strain of Gq-coupled receptors such as endothelin-1 and
angiontensin-1 stimulates PI3K and Akt, transactivating epidermal growth factor receptor to stimulate ERK and in turn the
plasma membrane Na+/H+ exchanger to provide a source of intracellular sodium [70].
An alternative is the activation of mechanosensitive cation channels that conduct sodium or calcium. These channels are
principally considered members of the transient receptor potential superfamily [71]. Recent studies have shown that the
Anrep or stress-stimulated contractility response is profoundly blunted by the activation of protein kinase G (PKG) via
cyclic GMP exposure [72] (Fig. 1.2B). Moreover, this modulation requires the presence of transient receptor potential cat-
ion channel, subfamily C6 (TRPC6), a mechanically activated canonical TRP channel expressed in cardiac myocytes (Fig.
1.2C). From a disease perspective, studies have found the Anrep response is particularly abnormal and likely contributes
to muscle disease in the dystrophinopathies. This was observed in cardiac myocytes from mice lacking dystrophin/utro-
phin where augmenting load during systole greatly augmented both the delayed calcium and force response, and triggered
arrhythmia. Blockade of TRPC6 (Fig. 1.2D) and activation of PKG normalized the response [72]. These data have placed
TRPC6 and potentially other interacting TRPC channels (as these proteins form heterotetramers) at the forefront of myo-
cyte mechanosensing, particularly in mechano-filament protein disorders.
Several studies have also proposed nitric oxide signaling is also important for mechanostress transduction [73,74],
although this may be model condition dependent as others find oxidant stress signaling but not NO as a major factor [75].
The precise mechanism remains unclear, though PKG inactivation of TRPC6 [76,77] or Gαq-receptor coupled signaling
to activation of G-coupled proteins (RGS2 or RGS4) [78,79] could provide a link between NO and mechanosensing.
Ventricular Systolic Function Chapter | 1 7
Lastly, in both intact hearts and muscle, the matricellular protein thrombospondin 4 plays a key role in transducing sys-
tolic stress; however, this does not apply in isolated myocytes, so this protein engages external but not internal systolic-
stress signaling [80].
8 SECTION | I Physiology and Molecular Basis of Muscle
different aspects so while they can be directionally altered in a similar manner, this is not always the case. The major limi-
tation to these easily assessed metrics is their modulation by noncardiac factors, namely, load applied by means of muscle
stretch (chamber filling), afterload (vascular impedance), or extrinsic constraints such as the pericardium. In the late 1970s
a method of depicting cardiac function based on plotting simultaneous cavity pressure and volume first developed by Otto
Frank [102] was resurrected and greatly refined by Sagawa, Suga, and colleagues [103]. This framework is now widely
used in genetically engineered mouse studies [104] up through and including human studies, and continues to be a gold-
standard for defining cardiac integrative function [82,105].
While not strictly required for its practical utility, an engineering concept behind pressure-volume (PV) analysis is that
heart muscle activation is a cyclical process of stiffening and de-stiffening, manifest as a time-varying elastance (elastance
is the inverse of chamber compliance). Passive PV relations define rest properties and as contractile proteins interact,
this relation steepens to reach a maximal slope at end-systole. At a constant sarcomere length (or chamber volume), stiff-
ness is directly proportional to force (or pressure). If muscle shortens, stiffness is the ratio of F/(L-Lo), where Lo is the
systolic muscle length at which no force is generated. Translated to the chamber, elastance is P/(V-Vo). Fig. 1.4A shows
simultaneous plots of left ventricular chamber volume (x-axis) and pressure (y-axis), with each heart cycle generating a
pressure-volume loop (loops move counterclockwise with time). The set of lines fanning from the origin reflect isochrones
(i.e., connecting points on each of the loops at the same instantaneous time in contraction). The slope of each line defines
0.6
LV Pressure (mmHg)
50 0.4
0.2
0 0.0
0 1 2
0 50 100
Normalized Time
LV Volume (mL)
(C)
(D)
FIGURE 1.4 (A) Time-varying elastance from isochrones derived from multiple cardiac cycles at varying preload volumes. The linear spokes connect
points on each loop at the same time in the cardiac cycle (isochrones), and their slope is the value of elastance at that time point [Elastance = Pressure/
(Volume−Vo)]. (B) The time-varying elastance is the change in this slope throughout the heartbeat (E(t)). When normalized for both peak and time to reach
peak, the waveform is remarkably conserved across species—as shown here for mouse and human. (C) Force-length relations obtained in a single cardiac
myocyte contracting against a simulated physiological load results in behavior very similar to that observed as pressure-volume relations in intact hearts.
(D) Time varying elastance curves in experimental model of heart failure in response to two different types of inotropic stimulation. On the left is the
response to the β1 agonist dobutamine, which increases the magnitude of elastance and also accelerates the kinetics of chamber stiffening/de-stiffening.
On the right is the response to the myosin ATPase activator, omecantiv mercarbil. In this case, contraction kinetics are prolonged, and relaxation is not
accelerated.
Ventricular Systolic Function Chapter | 1 9
the elastance (stiffness) of the chamber at that time, and this gradually rises from diastole to peak systole. The behavior
depicted from PV relations is similar to what can be obtained from a single-myocyte subjected to a “physiological” load
(Fig. 1.4B).
The overall shape (normalized to peak and time to peak) of time-varying elastance is remarkably conserved between
humans and other species including mouse (Fig. 1.4C) [106]. The curve is also conserved among human patients with a
broad range of heart diseases, or subjected to adrenergic or chronotropic stimulation [107]. This conservation has led to the
development of several methods to predict peak elastance, a measure of systolic function, from steady state contractions
[108,109]. There are examples where the elastance trajectory is altered, and this has provided some insight into its deter-
minants. As previously mentioned, mice lacking MyBP-C display a striking abbreviation of contraction, as crossbridge
interactions are not sustained when this protein is missing [18,110] (c.f. Fig. 1.1B). MyBP-C binds to the myosin heavy
chains S2 and tail regions [111,112] as well as actin [113] and is thought to impose a restraint on the kinetics of crossbridge
cycling, reducing filament velocity and rate of crossbridge attachment [114,115]. The latter was identified with acute length
perturbation studies, where force redevelopment reflected crossbridge kinetics. Another pertinent example is the cardiac
response to omecamtiv mecarbil [116], a myosin ATPase stimulator. This enhances the probability of a tightly bound cross-
bridge and so prolongs the systolic stiffening (Fig. 1.4D).
PV analysis was first applied in a comprehensive manner to humans in the mid-1980s, and was later miniaturized for
mouse studies in the late 1990s [104,117,118]. While most commonly used to study the left ventricle, right ventricle (RV)
relations have been obtained in animal models and recently employed to study human heart disease in forms of pulmonary
hypertension [119]. PV analysis provides multiple measures of systolic and diastolic function, including all of the standard
indexes discussed already, as well as end-systolic elastance (Ees). The latter is generally measured by the collection of points
(one per beat) where elastance is greatest for each beat. Fig. 1.5A displays human left ventricular (LV) pressure-volume data
obtained at rest and during transient reduction of preload volume. The bold loop represents the resting condition. The loop
width is stroke volume, ratio of width to end-diastolic volume is ejection fraction, and loop area is external (or stroke) work.
When ventricular preload is acutely reduced, stroke volume falls (Frank-Starling dependence).
These data appear different to what is almost universally depicted in physiology texts by way of a schematic, as the
upper left-hand corner of each loop does not land on the same point at the same pressure by end-systole (Fig. 1.5B). Texts
show it this way since preload is presumed not to alter “afterload,” and afterload is “assumed” to be equal to systolic pres-
sure, so one must reach the identical left-upper corner point. Clearly this does not actually happen, nor could it, since for
pressure to remain unchanged while stroke volume is declining with preload, the arterial resistive load would have to fall as
well and by exactly the right amount. Indeed, the steepness of the end-systolic PV relation is an important predictor of the
extent to which blood pressure will change when ventricular volumes are altered. Patients with hypertrophic and hyperdy-
namic hearts, typically have high Ees, and display a larger pressure drop with preload reduction as compared to those with
dilated depressed hearts and a low Ees [120].
150
Pressure (mm Hg)
80
100
40
50
0 0
0 100 200 0 10 20 30 40
FIGURE 1.5 Pressure-volume (PV) analysis of cardiac function. (A) Resting (dark solid loop) PV loop and multiple cycles derived by varying preload
in human subjects. Cycle loop moves counterclockwise. The lower right corner is end-diastole, the upper left is end-systole. The vertical regions on the
right and left are periods of isovolumic contraction and relaxation, respectively. The upper left corners of the set of loops define the end-systolic PV
relation, a valuable measure of chamber systolic function. (B) Depiction of a “pure preload change” as found in the majority of physiology text books.
The convergence of all the loop end-systolic points despite different starting end-diastolic volumes is non-physiological. This picture was taken from one
of many such diagrams off the internet. (C) Example of ventricular remodeling and cardiac systolic depression with sustained cardiac failure. Data are
generated using a mouse model of disease (MKK3 overexpression, activating p38 MAP kinase).
10 SECTION | I Physiology and Molecular Basis of Muscle
The end-systolic PV relation is commonly treated as linear, with slope Ees; however the actual data are often nonlinear.
This issue was first confronted in the 1980s [121,122], though it is rarely dealt with in contemporary studies using the ana-
lytic method in genetically engineered animals. Its impact is lessened if the range of pressures over which PV relations are
determined and compared is well matched, or nonlinear fits used that parameterize the curve without forcing a linear model.
Lastly, one can use curve-fit independent analysis to compare sets of systolic PV relations [18]. A different Ees value per se
does not necessarily translate to altered chamber contractility; its position along the volume axis must be considered as well
(Fig. 1.5C). Ees is also chamber geometry dependent, increasing in small hearts with identical myocardial/myocyte proper-
ties, and is impacted by interstitial matrix/vascular properties as well as myocyte properties. It is most easily interpreted
with acute modulations where these other factors are not altered, but can be normalized for chamber size and/or converted
to a stress–strain relation to enhance its specificity for contraction.
pressures at high volumes are no longer coupled to higher transmural distending pressures, due to concomitantly higher
extrinsic (pericardial) constraint. When preload declines, the actual transmural distending pressure can rise as this con-
straint is removed, so myocyte stretch increases despite the fall in EDP. Plots of cardiac output (CO) versus EDP can appear
biphasic, whereas those between CO and EDV are linear. This affects any relationship in which filling pressure is used to
index the level of chamber preload.
Ventricular–Arterial Interaction
Ventricular systolic function critically interacts with the vascular loading system into which the chamber ejects, and ven-
tricular-vascular coupling plays an important role in setting myocardial performance and efficiency. Fig. 1.7A shows a PV
$ % &
9ROXPH P/ 9ROXPH P/ 9ROXPH P/
FIGURE 1.7 (A) Resting human PV relations showing normal matching between end-systolic elastance (Ees) and arterial elastance (Ea). This matching
results in optimized cardiac function and efficiency. (B) In contrast, the failing heart displays a reduced Ees (depressed systolic function) and elevated Ea
(higher afterload). If afterload is reduced as shown in this example by administration of the arterial vasodilator, nitroglycerin, there is an increase in the
loop area (stroke work) and correspondingly a rise in ventricular power. (C) Ventricular arterial interaction is also abnormal in many patients with heart
failure and hypertrophic disease or a preserved ejection fraction. This is shown here, where a patient performed isometric hand exercise, and the result
was a large rise in systolic pressure and workload, and corresponding rise in diastolic pressures (lower boundary). The pressure change is predicted by the
higher resting elastance in this type of heart disease.
12 SECTION | I Physiology and Molecular Basis of Muscle
relation with a diagonal line slanting upward from right to left in each PV loop. The slope of this line is termed the effective
arterial elastance (Ea) [143–145] and is equal to the ratio of end-systolic pressure/stroke volume. Ea is not synonymous
with vascular stiffness; indeed its numeric value is mostly influenced by mean arterial resistance (Ea = ESP/SV ≈ R × HR).
However, it serves as a useful lumped measure of net ventricular after-load—both mean and pulsatile. Unlike arterial pres-
sure, Ea is essentially unaltered even if the filling volume in the heart is changed, as shown in the figure. Studies have used
this parameter in conjunction with PV relations and Ees to assess mechanisms of inodilator drugs [146] and examine heart-
vascular coupling in human disease conditions and in the general population [146–149].
The Ea/Ees ratio normally falls between 0.6 and 1.2, a range in which there is optimal transfer of energy or work (power
or SW) from the heart to arterial system [150–152]. Data from isolated canine hearts first displayed this dependence for
both work and cardiac efficiency, and subsequent studies confirmed similar relations in intact hearts [153]. Optimal match-
ing is maintained during exercise despite major alterations in contractility, HR, and vascular tone [152], and this may relate
to an evolutionary process designed to maintain efficiency of work transfer and a minimum relative cardiac/body size ratio
[154]. Work or power output is far from optimal, in hearts with depressed contractility and increased vascular loading, as
seen in failing dilated hearts [155], where this ratio can exceed 3 [146]. In such individuals, vasodilators result in improved
work (and power) (Fig. 1.7B), whereas in normal, they would have little net effect.
Combined increases in Ees and Ea can potently influence the pressures developed by the heart in response to changes
in chamber filling and arterial load. Increased ventricular systolic stiffening means that even small increases or decreases
in preload will amplify into marked changes in systolic pressure (Fig. 1.7C). This contributes to the increased diuretic and
orthostatic sensitivity in the elderly. In patients with cardiac failure symptoms yet ejection fraction >50%, such stiffening
is increased further [156]—though studies have shown this is likely related to the presence of systolic hypertension and
ventricular hypertrophy, both common features of HFpEF patients [147,157]. The hemodynamic consequence is greater
sensitivity of the heart to altered loading, exacerbated blood pressure liability, and potentially increased energetic demand
to deliver reserve cardiac output [156]. Indeed, growing evidence supports a central role of limited function reserve in this
disease, and these mechanical components likely contribute [158–160].
The systemic vasculature poses different loads on the LV than the pulmonary vessels do on the RV. This was highlighted by
studies examining the inverse dependence between total mean vascular resistance and lumped compliance for each respective bed
(e.g. systemic or pulmonary arteries). In the systemic circulation, vascular stiffening occurs in an anatomically distinct conduit
artery segment, much in the thoracic aorta, whereas the smaller distal arteries impose resistance. In the pulmonary bed, the rela-
tion is more tightly coupled in peripheral small vessels, so the compliance and resistance are less easily separable (Fig. 1.8A).
This has implications for ventricular-vascular coupling of the left versus right heart and corresponding vasculatures. For example,
increased LV pulsatile load which occurs with aging can exist without parallel increases in systemic vascular resistance. However,
in the RV, both components are linked. Therapies that reduce pulmonary vascular resistance rarely achieve the level required to
simultaneously meaningfully reduce pulsatile load related to low vascular compliance; thus, the RV remains subject to very high
afterload. Other studies have revealed that the LV diastolic filling pressure contributes a back-pressure to the pulmonary vascular
load, increasing the pulsatile load on the RV (Fig. 1.8B). This may contribute to a variety of heart diseases when LV diastolic
dysfunction can increase RV load during systole. Reduced pulmonary vascular compliance has been found to provide a strong
predictor for worsened outcome in heart failure patients with reduced [161] or preserved [162] ejection fraction.
$ %
&
3&:3 PP+JQ
3&:3! PP+JQ
3XOPRQDU\9DVFXODU&RPSOLDQFH P/PP+J
63+3+FRKRUW
\ [ 5
\ [ 5
3XOPRQDU\9DVFXODU5HVLVWDQFH PP+J 6 P/
FIGURE 1.8 (A) Reciprocal dependence of mean pulmonary vascular resistance versus total lumped vascular compliance in humans with primary
pulmonary hypertension. (B) This contrasts to a broader range of compliance and resistance in the systemic circulatory system. The differences lie in the
anatomic distribution of resistance and compliance in the two vascular beds (see text for details). (C) Increasing the LV end-diastolic pressure as indexed
by the mean pulmonary capillary wedge pressure has an impact on RV loading primarily by reducing the effective compliance and thus elevating pulsatile
load on the RV. This is being shown to predict worse outcomes in heart failure patients.
Improving myofilament calcium responsiveness continues to attract multiple therapy development programs. Referred
collectively as calcium sensitizers, these agents can target many different aspects from calcium–troponin C interaction
(levosimendan) [175] to ATPase (omecamtiv mercarbil) [116,176]. There are potential advantages of such agents given that they
bypass the adrenergic system, and so can work equally well in failing as in normal hearts. They also will have greater impact in
hearts where calcium desensitization has occurred, and in conditions where calcium response is augmented, as during exercise.
Thus, unlike other inotropic stimulators, these drugs can provide greater augmentation with stress than at rest.
Calcium sensitization has also been linked to a device-based therapy called cardiac resynchronization [177]. In this
case, hearts with discoordinate contraction due to electrical conduction delay receive biventricular stimulation to re-store
more synchronized contraction and improve chamber mechano-efficiency [178]. CRT improves both acute and chronic
cardiac function [179,180], yet does so in a manner that also improves mortality [181]. This remains unique among heart
failure therapies. While clearly impacting the heart at the chamber level, this therapy has been shown to confer surprising
benefits at the more molecular level [178]. In the case of myofilament function, Kirk et al. [177] found improvement in
calcium-sensitivity that was in turn linked to the re-activation of glycogen synthase kinase 3-beta. Ongoing efforts may lead
to a novel way to improve myofilament function and thus contractility safely.
Depressing systolic function on purpose in patients with hyperdynamic hearts, such as genetic hypertrophic cardiomy-
opathy with cavity obliteration, has also been a therapeutic target. Traditional negative inotropic agents such as beta-receptor
26 SECTION | I Physiology and Molecular Basis of Muscle
(A) (B)
(C) (D)
(E) (F)
FIGURE 2.4 Serial sections of normal human skeletal muscle stained for mATPase (dark areas in each panel) at (A) pH 4.3, (B) pH 4.6, and (C) pH
9.4 showing a reciprocal staining pattern of type 1 and 2 fibers at pH 4.3 and 9.4 and subdivision of type 2 fibers into 2A and 2B at pH 4.6; (D) section
stained for cytochrome c oxidase showing higher activity in type 1 fibers [1], low activity in type 2B (2B) fibers, and intermediate intensity of 2A (2A)
fibers corresponding to the varying number of mitochondria in each fiber type. Note also the peripheral areas of high activity corresponding to clusters of
mitochondria that are often adjacent to a capillary (arrow); (E and F) serial sections immunolabeled with antibodies to fast (F) and slow (E) myosin heavy
chains showing a reciprocal 2 fiber pattern with only an occasional hybrid fiber (*).
Another random document with
no related content on Scribd:
FRICASSEED FOWLS OR CHICKENS. (ENTRÉE.)
Skin and cut into joints one or two young chickens, and remove
the bones with care from the breasts, merrythoughts, and thighs,
which are to be separated from the legs. Mix well together a
teaspoonful of salt, nearly a fourth as much of mace, a little grated
nutmeg, and some cayenne; flatten and form into good shape, the
boned joints of chicken, and the flesh of the wings; rub a little of the
seasoning over them in every part, dip them into beaten egg, and
then into very fine bread-crumbs, and fry them gently in fresh butter
until they are of a delicate brown. Some of the bones and trimmings
may be boiled down in half a pint of water, with a roll of lemon-peel,
a little salt, and eight or ten white peppercorns, to make the gravy
which, after being strained and cleared from fat, may be poured hot
to some thickening made in the pan with a slice of fresh butter and a
dessertspoonful of flour: a teaspoonful of mushroom-powder would
improve it greatly, and a small quantity of lemon-juice should be
added before it is poured out, with salt and cayenne if required. Pile
the cutlets high in the centre of the dish, and serve the sauce under
them, or in a tureen.
CUTLETS OF FOWLS, PARTRIDGES, OR PIGEONS. (ENTRÉE.)
(French Receipt.)
Take closely off the flesh of the breast and wing together, on either
side of the bone, and when the large fillets, as they are called, are
thus raised from three birds, which will give but six cutlets, take the
strips of flesh that lie under the wings, and that of the merrythoughts,
and flatten two or three of these together, that there may be nine
cutlets at least, of equal size. When all are ready, fry to a pale brown
as many diamond-shaped sippets of bread as there are fillets of fowl,
and let them be quite as large; place these before the fire to dry, and
wipe out the pan. Dip the cutlets into some yolks of eggs, mixed with
a little clarified butter, and strew them in every part with the finest
bread-crumbs, moderately seasoned with salt, cayenne, and
pounded mace. Dissolve as much good butter as will be required to
dress them, and fry them in it of a light amber-colour: arrange them
upon the sippets of bread, pile them high in the dish, and pour a rich
brown gravy or Espagnole round, but not over them.
FRIED CHICKEN À LA MALABAR. (ENTRÉE.)
This is an Indian dish. Cut up the chicken, wipe it dry, and rub it
well with currie-powder mixed with a little salt; fry it in a bit of butter,
taking care that it is of a nice light brown. In the mean time cut two or
three onions into thin slices, draw them out into rings, and cut the
rings into little bits about half an inch long; fry them for a long time
gently in a little clarified butter, until they have gradually dried up and
are of a delicate yellow-brown. Be careful that they are not burnt, as
the burnt taste of a single bit would spoil the flavour of the whole.
When they are as dry as chips, without the least grease or moisture
upon them, mix a little salt with them, strew them over the fried
chicken, and serve up with lemon on a plate.
We have extracted this receipt from a clever little work called the
“Hand-Book of Cookery.”
HASHED FOWL. (ENTRÉE.)
Raise from the bones all the more delicate parts of the flesh of
either cold roast, or of cold boiled fowls, clear it from the skin, and
keep it covered from the air until it is wanted for use. Boil the bones
well bruised, and the skin, with three quarters of a pint of water until
reduced quite half; then strain the gravy and let it cool; next, having
first skimmed off the fat, put it into a clean saucepan, with a quarter
of a pint of cream, an ounce and a half of butter well mixed with a
dessertspoonful of flour, and a little pounded mace, and grated
lemon-rind; keep these stirred until they boil, then put in the fowl,
finely minced, with three or four hard-boiled eggs chopped small,
and sufficient salt, and white pepper or cayenne, to season it
properly. Shake the mince over the fire until it is just ready to boil, stir
to it quickly a squeeze of lemon-juice, dish it with pale sippets of fried
bread, and serve it immediately. When cream cannot easily be
obtained, use milk, with a double quantity of butter and flour. To
make an English mince, omit the hard eggs, heat the fowl in the
preceding sauce or in a common béchamel, or white sauce, dish it
with small delicately poached eggs (those of the guinea-fowl or
bantam for example), laid over it in a circle and send it quickly to
table. Another excellent variety of the dish is also made by covering
the fowl thickly with very fine bread-crumbs, moistening them with
clarified butter, and giving them colour with a salamander, or in a
quick oven.[90]
90. For minced fowl and oysters, follow the receipt for veal, page 231.
FRITOT OF COLD FOWLS.
Cut into joints and take the skin from some cold fowls lay them into
a deep dish, strew over them a little fine salt and cayenne, add the
juice of a lemon, and let them remain for an hour, moving them
occasionally that they may all absorb a portion of the acid; then dip
them one by one into some French batter (see Chapter V.), and fry
them a pale brown over a gentle fire. Serve them garnished with very
green crisped parsley. A few drops of eschalot vinegar may be mixed
with the lemon-juice which is poured to the fowls, or slices of raw
onion or eschalot, and small branches of sweet herbs may be laid
amongst them, and cleared off before they are dipped into the batter.
Gravy made of the trimmings, thickened, and well flavoured, may be
sent to table with them in a tureen; and dressed bacon (see page
259), in a dish apart.
SCALLOPS OF FOWL AU BÉCHAMEL. (ENTRÉE.)
Raise the flesh from a couple of fowls as directed for cutlets in the
foregoing receipt, and take it as entire as possible from either side of
the breast; strip off the skin, lay the fillets flat, and slice them into
small thin scallops; dip them one by one into clarified butter, and
arrange them evenly in a delicately clean and not large frying-pan;
sprinkle a seasoning of fine salt over, and just before the dish is
wanted for table, fry them quickly without allowing them to brown;
drain them well from the butter, pile them in the centre of a hot dish,
and sauce them with some boiling béchamel. This dish may be
quickly prepared by taking a ready-dressed fowl from the spit or
stewpan, and by raising the fillets, and slicing the scallops into the
boiling sauce before they have had time to cool.
Fried, 3 to 4 minutes.
GRILLADE OF COLD FOWLS.
Carve and soak the remains of roast fowls as for the fritot which
precedes, wipe them dry, dip them into clarified butter, and then into
fine bread-crumbs, and broil them gently over a very clear fire. A little
finely-minced lean of ham or grated lemon-peel, with a seasoning of
cayenne, salt, and mace, mixed with the crumbs will vary this dish
agreeably. When fried instead of broiled, the fowls may be dipped
into yolk of egg instead of butter; but this renders them too dry for
broiling.
FOWLS À LA MAYONNAISE.
Carve with great nicety a couple of cold roast fowls; place the
inferior joints, if they are served at all, close together in the middle of
a dish, and arrange the others round and over them, piling them high
in the centre. Garnish them with the hearts of young lettuces cut in
two, and hard-boiled eggs, halved lengthwise. At the moment of
serving, pour over the fowls a well-made mayonnaise sauce (see
Chapter VI.), or, if preferred, an English salad-dressing, compounded
with thick cream, instead of oil.
TO ROAST DUCKS.
[Ducks are in season all the year, but are thought to be in their
perfection about June or early in July. Ducklings (or half-grown
ducks) are in the greatest request in spring, when there is no game
in the market, and other poultry is somewhat scarce.]
In preparing these for the spit, be careful
to clear the skin entirely from the stumps of
the feathers; take off the heads and necks,
but leave the feet on, and hold them for a
few minutes in boiling water to loosen the
skin, which must be peeled off. Wash the
inside of the birds by pouring water through
Ducks trussed.
them, but merely wipe the outsides with a
dry cloth. Put into the bodies a seasoning of
parboiled onions mixed with minced sage, salt, pepper, and a slice of
butter when this mode of dressing them is liked; but as the taste of a
whole party is seldom in its favour, one, when a couple are roasted,
is often served without the stuffing. Cut off the pinions at the first joint
from the bodies, truss the feet behind the backs, spit the birds firmly,
and roast them at a brisk fire, but do not place them sufficiently near
to be scorched; baste them constantly, and when the breasts are
well plumped, and the steam from them draws towards the fire, dish,
and serve them quickly with a little good brown gravy poured round
them, and some also in a tureen; or instead of this, with some which
has been made with the necks, gizzards, and livers well stewed
down, with a slight seasoning of browned onion, some herbs, and
spice.
Young ducks, 1/2 hour: full sized, from 3/4 to 1 hour.
Obs.—Olive-sauce may be served with roast as well as with
stewed ducks.
STEWED DUCK. (ENTRÉE.)
Truss them like boiled fowls, drop them into plenty of boiling water,
throw in a little salt, and in fifteen minutes lift them out, pour parsley
and butter over, and send a tureen of it to table with them.
CHAPTER XV.
Game.
TO CHOOSE GAME.
Hares and rabbits are stiff when freshly killed, and if young, the
ears tear easily, and the claws are smooth and sharp. A hare in cold
weather will remain good from ten to fourteen days; care only must
be taken to prevent the inside from becoming musty, which it will do
if it has been emptied in the field. Pheasants, partridges, and other
game may be chosen by nearly the same tests as poultry: by
opening the bill, the staleness will be detected easily if they have
been too long kept. With few exceptions, game depends almost
entirely for the fine flavour and the tenderness of its flesh, on the
time which it is allowed to hang before it is cooked, and it is never
good when very fresh; but it does not follow that it should be sent to
table in a really offensive state, for this is agreeable to few eaters
and disgusting to many, and nothing should at any time be served of
which the appearance or the odour may destroy the appetite of any
person present.
TO ROAST A HAUNCH OF VENISON.